Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Wallander

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Primary Health Care. Supplement|January 1, 1990
Safety in clinical trialsM A Wallander
Drug Safety|March 1, 1993
The way towards adverse event monitoring in clinical trialsM A Wallander
European Journal of Clinical Pharmacology|January 1, 1992
Adverse event monitoring in clinical trials of felodipine and omeprazoleM A Wallander, P Lundborg, K Svärdsudd
Journal of Cardiovascular Pharmacology|January 1, 1990
Felodipine safety evaluation: adverse event patternA Kennerfalk, P Lundborg, M A Wallander
Journal of Clinical Epidemiology|July 6, 2000
Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden: A population-based studyA Bardel, M A Wallander, K Svärdsudd
Pharmacoepidemiology and Drug Safety|April 10, 2004
Geographical variation in adverse event reporting rates in clinical trialsS Joelson, I B Joelson, M A Wallander
European Journal of Clinical Pharmacology|January 1, 1991
Aspects of quality of life on treatment with felodipineE Dimenäs, M A Wallander, K Svärdsudd, et al.
International Journal of Clinical Practice|February 19, 2009
Aspirin in cardiology--benefits and risksL Björklund, M-A Wallander, S Johansson, et al.
Scandinavian Journal of Gastroenterology|April 21, 1998
The introduction of H2-receptor antagonists to Scandinavia: effects of experts' opinionsH Molinder, M A Wallander, K Svärdsudd, et al.
Scandinavian Journal of Gastroenterology|December 3, 1999
Dyspepsia--acid or stress? A study of controversy. Abandoned by experts, finalized in clinical practice?H Molinder, M A Wallander, M Hallberg, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Primary Health Care. Supplement|January 1, 1990
Safety in clinical trialsM A Wallander
Drug Safety|March 1, 1993
The way towards adverse event monitoring in clinical trialsM A Wallander
European Journal of Clinical Pharmacology|January 1, 1992
Adverse event monitoring in clinical trials of felodipine and omeprazoleM A Wallander, P Lundborg, K Svärdsudd
Journal of Cardiovascular Pharmacology|January 1, 1990
Felodipine safety evaluation: adverse event patternA Kennerfalk, P Lundborg, M A Wallander
Journal of Clinical Epidemiology|July 6, 2000
Reported current use of prescription drugs and some of its determinants among 35 to 65-year-old women in mid-Sweden: A population-based studyA Bardel, M A Wallander, K Svärdsudd
Pharmacoepidemiology and Drug Safety|April 10, 2004
Geographical variation in adverse event reporting rates in clinical trialsS Joelson, I B Joelson, M A Wallander
European Journal of Clinical Pharmacology|January 1, 1991
Aspects of quality of life on treatment with felodipineE Dimenäs, M A Wallander, K Svärdsudd, et al.
International Journal of Clinical Practice|February 19, 2009
Aspirin in cardiology--benefits and risksL Björklund, M-A Wallander, S Johansson, et al.
Scandinavian Journal of Gastroenterology|April 21, 1998
The introduction of H2-receptor antagonists to Scandinavia: effects of experts' opinionsH Molinder, M A Wallander, K Svärdsudd, et al.
Scandinavian Journal of Gastroenterology|December 3, 1999
Dyspepsia--acid or stress? A study of controversy. Abandoned by experts, finalized in clinical practice?H Molinder, M A Wallander, M Hallberg, et al.
Pageof 6